NEW YORK, NY / ACCESS Newswire / July 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Encompass Health Corporation ("Encompass" or "the Company") (NYSE:EHC). Investors who purchased Encompass securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/EHC.
Investigation Details
On July 15, 2025, The New York Times published an article alleging, among other things, that federal data and inspection reports show that for-profit hospitals run by Encompass perform below average on key safety measures. The article revealed "Encompass owns many of the rehabs with worse rates of potentially preventable, unplanned readmissions to general hospitals" including 34 facilities which "Medicare rated as having statistically significantly worse rates of potentially preventable readmissions." The report further revealed a number of "alarming mistakes" leading to fatalities of patients in their care. Following this news, Encompass stock dropped.
What’s Next?
If you are aware of any facts relating to this investigation or purchased Encompass securities, you can assist this investigation by visiting the firm’s site: bgandg.com/EHC. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contact
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com
SOURCE: Bronstein, Gewirtz & Grossman, LLC
View the original press release on ACCESS Newswire
COMTEX_467400986/2457/2025-07-17T12:46:08